Mrs.Ruth Devenyns

Independent Director, representing Hasseltberg BVBA

Mrs Devenyns has a long standing experience in healthcare financing. She began her career with KBC in the Economic Research Department. She joined KBC Securities in 1995 and established KBC’s investment banking franchise in healthcare, initially as a sell-side analyst and subsequently on the banking side. She moved to the buy-side around 2000 and successfully built and managed a >EUR 120m portfolio of private biotech companies in Belgium and abroad. Mrs Devenyns left KBC in 2012 to become an independent consultant, offering investment/financial advisory & director services with a focus on healthcare. In that capacity, she worked for Korys, the Colruyt family office, and Bank Degroof Petercam, supporting the healthcare investment banking activities. She joined Ogeda, a clinical-stage drug discovery company, as CFO in March 2016.